Silver Book Fact

Subthalamic nuclei deep brain stimulation (STN-DBS) raises pain thresholds in Parkinson’s disease patients.

Dellapina, Estelle, Fabienne Ory-Magne, Wafa Regragui, Claire Thalamas, Yves Lazorthes, Olivier Rascol, and Christine Brefel-Courbon. Effect of Subthalamic Deep Brain Stimulation in Parkinson’s Disease. Pain. 2012; 153(11): 2267-73. http://www.painjournalonline.com/article/S0304-3959(12)00453-8/abstract

Reference

Title
Effect of Subthalamic Deep Brain Stimulation in Parkinson’s Disease
Publication
Pain
Publication Date
2012
Authors
Dellapina, Estelle, Fabienne Ory-Magne, Wafa Regragui, Claire Thalamas, Yves Lazorthes, Olivier Rascol, and Christine Brefel-Courbon
Volume & Issue
Volume 153, Issue 11
Pages
2267-73
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • People with persistent pain who used complementary and alternative medicine (CAM) had lower average health care expenditures than nonusers ($3,797 versus $4,153).  
  • Topical NSAIDs were found in a meta-analysis to be significantly more effective than placebo in reducing persistent pain from musculoskeletal conditions.  
  • In individuals with persistent low back pain, tanezumab, a humanized anti-nerve growth factor antibody, showed clinical and statistical analgesic efficacy that was superior to placebo and naproxen.  
  • The Mayo Clinic Pain Rehabilitation Center helps people with persistent pain return to an active lifestyle and has found that among patients who finish the program, nearly 84% report greater…  
  • Targeting A-type K+ channels in primary sensory neurons could provide a novel mechanism-based therapy for the treatment of bone cancer pain–one of the most severe types of chronic pain.